Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain trends, and present findings clearly across business, finance, product, and ...

UC San Diego cognitive scientist Philip Guo created Python Tutor, a free tool that makes code “visible” step by step. The research behind it earned a Test of Time award, recog ...

Astral tools and expertise will be leveraged in OpenAI Codex agentic coding app to expand AI capabilities across the software ...

Breez SDK now supports Passkey Login, allowing developers to build self-custodial Bitcoin wallets without mandatory seed phrases using FIDO2 PRF extensions for deterministic key derivation.

GlassWorm campaign injects malware into GitHub Python repos using stolen tokens since March 8, 2026, exposing developers to ...

Python is now one of the fastest-growing programming languages being used globally and supports machine-learning-based ...

Overview: Automated Python EDA scripts generate visual reports and dataset summaries quicklyLibraries such as YData Profiling ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...